YLQ-18852-39269
4 vaccinations
3 coded responses
38 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 802 / CO
- Registered
- 2021-04-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-17
Registered in v-safe
- 2021-04-17
-
2021-04-23
Dose 2 — Pfizer-BioNTech
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-07-23
- 2021-10-22
-
2021-11-03
Dose 3 — Moderna
-
2021-11-09
Survey response — days 1–6 daily, dose 3MedDRA: Lymphoedema — Feeling: Good · Site: Pain · Be unable to do your normal daily activitiesFree text: LymphedemaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-11
Survey response — day 7, dose 3MedDRA: Lymphoedema — Feeling: GoodFree text: LymphedemaMedDRA releases: 2024-11 · check-in free text available
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2022-02-02
- 2022-05-04
-
2022-09-09
Dose 4 — Moderna
-
2022-09-10
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-11
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-12
- 2022-09-13
- 2022-09-14
-
2022-09-16
Health check-in — day 7, dose 4Feeling: Poor · Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2022-09-16
Report sent to call center — day 7, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-19
-
2022-09-23
Survey response — day 14, dose 4MedDRA: Fatigue, Headache, Oropharyngeal pain — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fatigue, sore throat, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-09-23
Report sent to call center — day 14, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-09-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-12-09
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-11-03 | Moderna | No |
| 4 | 2022-09-09 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-16 | Successful 2022-09-26 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-09-23 | Successful 2022-09-26 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lymphedema
Release 10 — day 7, dose 3
Systemic reaction (other): Lymphedema
Release 12 — day 14, dose 4
Symptoms: Fatigue, sore throat, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SRO | Lymphoedema | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release